Search results
Ono Pharmaceutical acquires cancer-focused biopharma Deciphera for $2.4bn
Pharmaceutical Technology via Yahoo Finance· 1 day agoIn September 2023, Ono signed a drug discovery collaboration agreement with Adimab for the...
US FDA grants full approval for Pfizer's cervical cancer drug
Reuters via AOL· 22 hours agoThe treatment, Tivdak - an antibody-drug conjugate co-developed by Genmab A/S and Seagen - received...
Gilead gives up on $4.9B antibody as solid tumor plan unravels
FierceBiotech· 4 days agoA $4.9 billion hole has appeared in Gilead Sciences' pipeline. After years of setbacks, the Big Biotech dealt a final blow to its anti-CD47 monoclonal antibody magrolimab ...
Coming to a CVS Near You: A Store Brand Monoclonal Antibody
The Wall Street Journal· 1 day agoHEARD ON THE STREET Most shoppers are familiar with CVS Health many private-label products, from...
The antibody was able to prevent seasonal malaria in children with a single dose
Hardwood Paroxysm· 4 days agoThe effectiveness of the antibody, which has already been tested in adults, It was tested on children in Mali for 6 months Which disease continues to occur in this country ...
Pfizer cervical cancer drug gets full approval
Becker’s Hospital Review· 11 hours agoThe FDA has granted full approval for Pfizer's Tivdak (tisotumab vedotin-tftv) to treat cervical cancer in patients whose disease has progressed on or after chemotherapy. The treatment is the ...
Monoclonal antibody offers strong malaria protection in children
Center for Infectious Disease Research and Policy· 4 days agoShare Copied to clipboard Today in the New England Journal of Medicine a study demonstrates that a...
Q&A on Reducing COVID-19 Risk for Elderly, Immunocompromised - FactCheck.org
FactCheck.org· 7 days agoThe updated COVID-19 vaccines and, in some cases, a new monoclonal antibody can provide increased protection for this group. “At this point, many people have had multiple ...
Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting
Yucaipa News Mirror· 6 days ago...manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announces that about 20 accepted abstracts of clinical data from multiple trials in relation to multiple novel mono-/bi-specific...
SynOx takes rare tumour treatment to phase 3 with $75m Series B
BioPharma-Reporter· 1 day agoThe UK/Irish company SynOx Therapeutics plans to run a phase 3 trial of a potentially best-in-class ...
